Avsnitt
-
Kaustubh Deshpande is the Co-Founder of Eywa Neuro. He previously spent time as an engineer at Neuralink and NeuroNexus. In our conversation we discuss clinical translation, the neurotech startup space, running your own company, India’s neurotech ecosystem, the founding of Eywa Neuro, the future of Eywa Neuro, how to break into neurotech, and more! Recorded: January 15, 2024. Hosts: Robert Murcko and Yuqing Wang.
Key Moments:
0:00 Intro
8:13 Initial Interest in Neurotechnology
13:07 Clinical Translation Wisdom
16:39 Polyimide Trade Space
22:17 Building Your Own Company vs Working at a Startup
27:14 India’s Neurotech Ecosystem
32:07 Future of Eywa Neuro
34:47 Does neurotech need more experts from a certain domain?
38:58 How to break into neurotech
44:34 Future of Neurotech
50:27 Conclusion
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Kaustubh Deshpande LinkedIn: https://www.linkedin.com/in/kaustubh-deshpande-3931b8157/
Eywa Neuro: https://eywaneuro.com/
Ridge Biosignals: https://ridgebiosignals.beehiiv.com/subscribe
-
James Hamet has been working in AI and neurotech since his undergrad days. He is a serial neurotech founder and has been deeply involved with both Neurable and Vistim Labs. Our interview covers a range of topics: his early days in neurotech, lessons learned from his time at Neurable, an overview of Vistim’s products/tech, his vision for the future of the space (both short term and long term), the differences between going bootstrapped vs VC-funded, advice for founders, and more. Recorded: March 7, 2024. Host: Robert Murcko.
Key Moments:
0:00 Intro
3:45 Initial Involvement in Neuroscience/Neurotech
7:29 Founding of Vistim Labs
10:30 Learnings from Neurable Inform Current Work
13:25 Venture Funding Pros/Cons
19:00 Vistim Labs Tech/Product
22:47 Vistim Labs Involvement w/ Research & Academia
25:47 Researchers are kind of like investors
26:23 Vistim Labs Competitors
31:01 Vistim Labs Short-Term Future
33:23 The Secret of All Business
35:10 Vistim Labs Long-Term Vision
40:50 Advice for Breaking Into Neurotech
44:50 The Future of Neurotech
48:57 Conclusion
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
James Hamet LinkedIn: https://www.linkedin.com/in/jchamet/
Ridge Neurotech: https://ridgeneurotech.beehiiv.com/subscribe
-
Saknas det avsnitt?
-
Interview with Yacine Achiakh. He is the CEO and co-founder of Wisear, a company working on building the neural interface and human-machine interface platform technology of the future. Their goal is to enable people to have seamless, voiceless, and touchless control over their everyday devices. Their first application of this technology is earbuds outfitted with electrodes that can pick up biosignals (EEG, EMG, EOG, etc.) and convert them into control signals for various devices. This episode is jam-packed with interesting and useful information from start to finish.
Yacine and I talk for over an hour discussing a range of topics like: his career journey before founding Wisear, quitting his job to start the company, inspiration from Neuralink, scrappy early stage building & prototyping, development of Wisear’s technology stack, techniques to reduce electromagnetic noise, strategic decisions to get their product into more hands, the value of collecting data, hardware agnostic technology frameworks, possible research partnerships, neural interfaces & human-machine interfaces of the future, the changing form factors of our devices & interactions with technology, advice for students, advice for founders, the interconnected neurotech community, why its hard to bootstrap in neurotech, why its useful to raise a large first round of venture capital funding in neurotech, short term future of neurotechnology, long term future of neurotechnology, and neurotech’s upcoming eventual “GenAI moment.”
At the conclusion of the episode, Yacine gives a brief demonstration of Wisear’s technology and discusses opportunities to become part of Wisear’s alpha testing group, beta testing group, or the broader community that they are working to build. Recorded March 28, 2024. Host: Robert Murcko
Key Moments:
0:00 Introduction
3:00 Initial Interest in Neurotechnology/Neuroscience
4:04 Inspiration from Neuralink (SF Soccer Game)
7:55 Wisear’s Founding
8:49 Quitting Job and Scrappy Tinkering
10:24 Human-Machine Interface: Control
11:42 Early Prototype
12:47 Early Funding and Hiring a Small Team
13:54 Product and Technology Overview
20:32 Neural Interface Platform Tech: Form Agnostic (Earphones, Glasses, etc.)
21:47 A Community of Users
23:02 Wisear Silent Speech Controls
25:51 Use Cases of Wisear’s Existing Products and Technology
30:18 Wisear Applications in Augmented Reality
33:15 Neurotech CEO: Day-to-Day
38:02 Background in AI and Management at Criteo Informing Wisear
43:07 Wisear’s Competitors and the Vibrant Neurotech Community
46:37 Next Steps and Future Vision for Wisear
50:25 Advice for Breaking Into Neurotech
54:49 Advice for Neurotech Founders
58:13 Neurotechnology Predictions
1:00:52 Wisear Demo
1:03:38 Conclusion
Free Neurotechnology Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Wisear Website: https://www.wisear.io/
Yacine Achiakh’s LinkedIn: https://www.linkedin.com/in/yacineachiakh/
Robert Murcko’s LinkedIn: https://www.linkedin.com/in/robert-murcko/
-
Interview with VCU Bioengineering Research Scientist Dr. Geetanjali Bendale. Some of the topics we discuss include her current work in nerve repair and regeneration, her past work in bioelectronics/neurotechnology, translating basic science into the clinic, partnerships with surgeon scientists, the future of neurotech, and advice for students looking to get into this space. Recorded January 15, 2024. Host: Robert Murcko
Key Moments:
0:00 Introduction
6:38 Initial Interest in Neuroscience?
7:18 Dreams of Being a Surgeon
9:53 Amazed by the Details of Neurobiology
12:43 Neuromodulation w/ Miniature Wireless Stimulator for Small Peripheral Nerves
16:18 Direct Vagus Nerve to Spleen Communication Discovered
20:56 Nerve Tape: Sutureless Coaptation Device to Repair Peripheral Nerve Defects
29:43 Neuromuscular Repair - Current Research Focus and Future Directions
34:20 Autograft vs Allograft
37:05 Predictions for the Future of Neurotechnology
43:57 Tips for Students Looking to Build a Career in Neurotech
47:44 Conclusion and Contact Information
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Bendale’s LinkedIn: https://www.linkedin.com/in/geetanjali-bendale-1844a834/
-
Interview with Greg Alden. He is the CEO of Diagnostic Biochips – a company providing high fidelity research tools to neuroscientists for electrophysiology and more. He spent the early years of his career optimizing data communications to solve big problems in the domains of broadband and mobile communications. He now brings this set of useful expertise to the neurotech world. We have a conversation talking about everything from the future of neurotechnology innovation, Greg’s journey into the field (in part sparked by his diagnosis with a neurological condition), management principles for a technical organization, and more! Recorded January 16, 2024. Hosts: Robert Murcko andYuqing Wang.
Key Moments
0:00 Intro
1:54 Parkinson’s Diagnosis
3:06 Applying Tech to Neuro Problems
4:08 Brain as a Distributed Computing Networking Function
5:03 Interest in Neuroscience
7:14 Involvement with Diagnostic Biochips
9:46 Commercialization of Diagnostic Biochips’ Products
11:30 Transitioning from Telecom to Neurotech
14:03 Market Landscape and Diagnostic Biochips’ Place In It
17:21 From Idea Stage through Go-to-Market
21:20 Advice for Academics Looking to Translate Their Technology
23:59 Technical vs. Business Priorities
26:29 Diagnostic Biochips’ Products and Offerings
29:28 Cloud-Based Analysis Platform
35:24 Diagnostic Biochips Contributions to the Field ofNeuroscience
40:03 Advice for Getting Involved with Neurotech
42:23 The Future of Neurotechnology
46:42 Conclusion and Contact Information
Links
Free Neurotech Newsletter:
https://neurotechnologynews.beehiiv.com/subscribe
Diagnostic Biochips: https://diagnosticbiochips.com/
Greg’s LinkedIn: https://www.linkedin.com/in/gregjalden/
-
Interview with Dr. Matthew Wall. He is a neuroscientist, psychologist, and fMRI (brain imaging) specialist with Imperial College London and Invicro (a CRO focused on medical imaging). His research has explored the domains of neuropsychopharmacology, addiction, psychedelics, cannabis, sex hormones, pain, weight loss, and much more. We discuss Dr. Wall’s journey into the field, his recent projects, innovations in fMRI & medical imaging, how AI is going to change everything, and the future of neurotech. Recorded January 11, 2024. Host: RobertMurcko
Key Moments
0:00 Intro
3:56 What are you working on now? (Sex, Cannabis, Psychedelics, and more)
15:26 Scientific Theories Behind Psychedelic Applications in Mental Health
19:18 FDA and Psychedelics
20:36 Innovations in fMRI Imaging Over the Years
24:50 Contribution of AI to fMRI and Neuroimaging Innovation
26:53 Background on Data Streams an fMRI Scanner Provides
29:14 PETxfMRI & EEGxfMRI
32:25 fMRI Brain-Computer Interfaces
35:16 Related modalities: fNIRS, MEG
36:12 Minimizing fMRI and why its so large
37:49 Bedside fMRI
38:11 Predictions for the Future of Neurotech and fMRI
45:21 Conclusion and Contact Information
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Wall’s Link Tree: https://linktr.ee/mbwall
-
Interview with Michael Byrne, the CEO and Co-Founder of sleep-focused neurotech startup, Bia Neuroscience. We discuss the importance of sleep, Michael’s journey into the realm of sleep technology, Bia’s product and differentiation, finding technical co-founders, team building as a business focused executive, aligning business/technical strategies, the future of neurotech, advice for young people looking to break into the space, and more! Recorded March 20, 2024. Host: Robert Murcko
Key Moments
0:00 Intro
4:38 Initial Interest in Neuroscience and Neurotechnology
5:50 Interest in Sleep
7:45 Founding Story of Bia Neuroscience
9:57 Bia’s Product: Capabilities and Customer Fit
12:31 Audio Component of Bia’s Product
14:10 Bia Neuroscience’s Competitors and Market Landscape
15:51 Finding Technical and Scientific Co-Founders
17:44 Finding Technical Staff
20:24 Skills and Mindsets for Being an Operator in a Technical Space
23:05 Ego (Don’t Be Scared to Ask “Dumb Questions”)
24:10 Aligning Business Strategy with Technical Goals
28:20 Day-to-Day for a Neurotech Executive
31:11 Advice for Breaking into Neurotech
33:11 Advice for Neuroscience or Neurotech Co-Founders
35:32 Future of Neurotechnology
38:18 Content Recommendations
39:41 Conclusion and Contact Info
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Bia Neuroscience Website: https://getbia.com/
Michael Byrne’s LinkedIn: https://www.linkedin.com/in/michael-kp-byrne/
Michael Byrne’s E-Mail: [email protected]
-
Interview with Caitlin Baltzer, the CEO and Co-Founder of neuroimaging and brain analytics startup, MYndspan. She shares some details about Magnetoencephalography (MEG), the modality her startup uses for neuroimaging. She also gives us the story behind MYndspan’s founding and how she ended up where she is today. You’ll see some clues about what’s next for MYndspan and a short conversation about the future of neurotech at large. Recorded March 18, 2024. Host: Robert Murcko
Key Moments:
0:00 Intro
4:50 Initial Interest in Neuroscience and Neurotechnology
6:43 MYndspan Founding and Timeline
10:20 Imaging and Report Generation Process (User Experience)
12:14 Idea for MYndspan: Eureka Moment or Slow Buildup
13:56 Brain Analytics
17:02 Magnetoencephalography (MEG) Explanation
20:18 MYndspan’s Key Product
23:31 Direct-to-Consumer (D2C) Framework
24:11 MYndspan’s Locations
25:08 CEO with Banking and Strategy Background
26:30 Topics Caitlin is Passionate About
27:32 Transition from COO to CEO
29:42 Day-to-Day for a CEO
31:02 A Rising Tide Lifts All Boats
32:36 MYndspan’s Differentiation and Competitors
34:40 What’s next for MYndspan
36:23 Advice: You Don’t Need a Perfect Plan
38:30 Future of Neurotechnology
41:49 Conclusion and Contact Info
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
MYndspan Website: https://myndspan.com/
-
Interview with Dr. Avinash Singh. He is a professor at the University of Technology, Sydney working on Neuroadaptive brain-computer interfaces, neuroethics, and standardization in the space ofneurotechnology. Recorded January 8, 2024. Host: Robert Murcko
Key Moments:
0:00 Intro
2:16 Initial Interest in Neurotechnology
5:03 Dr. Warwick’s Early Brain-Computer Interface
6:17 Transition into Neurotech
9:37 Standardization in the BCI Research Community
16:56 Neuro-Adaptive BCIs
23:21 Neural Signature of Prediction Error
26:30 Machine Learning (Reinforcement Learning with Human Feedback) for Neuro-Adaptive BCIs
33:32 Neuroethics
41:23 Transhumanism
49:02 Future of Neurotechnology
55:58 Conclusion and Contact Info
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Singh UT Sydney Profile: https://profiles.uts.edu.au/Avinash.Singh
Dr. Singh LinkedIn: https://www.linkedin.com/in/avinashks/
-
Interview with Dr. Christoph Guger, the CEO of g.tec Medical Engineering and an innovator in the field of neurotechnology and BCI. We have a wide ranging discussion spanning from his personal journey to get to where he is today, specifics about his company, the early days of neurotechnology, the future of neurotechnology, and more! Recorded January 24, 2024. Host: Robert Murcko
Key Moments:
0:00 Intro
2:21 Initial Interest in Neurotechnology
3:28 Background on g.tec
8:11 RecoveriX
14:03 EEG Biomarker of Neuroplasticity
15:55 g.tec Brain Computer Interface System (g.bcisys)
19:25 Recording physiological and pathological cortical activity and exogenous electric fields using graphene microtransistor arrays in vitro
23:50 g.tec’s Educational and Community Initiatives in the Neurotechnology Space (BCI Award, Spring School, etc.)
29:19 What is next for g.tec?
31:59 Advice for students or young professionals looking to work in neurotech
34:09 Predictions for the Future of Neurotech (next 20 years)
36:27 Closing Remarks and Dr. Guger’s Contact Info
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
gtec website: https://www.gtec.at/
-
Interview with Dr. Marijin Lijffijt who is a neuropsychopharmacologist by training and now works as a consultant for various biotech and pharma start-ups. We talk about his transition from being a PI in academia to the start-up world, some of the projects related to EEG biomarkers that he is currently working on, how relatively little the world knows about mental health disorders, paths to finding out more about these disorders (which may lead to better treatments and identification), the future of neurotech, and more! Recently he has worked with Sage Therapeutics and Sama Therapeutics. Recorded January 2, 2024. Host: Robert Murcko
Key Moments:
0:00 Intro
5:50 Transition from Academia Into Startups
13:00 Dr. Lijffijt’s projects with Sama Therapeutics
24:18 Brief discussion about AI and machine learning and how they are revolutionizing the field of biotech
26:09 Predictions for the future of neurotech
33:51 Closing remarks and Dr. Lijffijt’s contact information
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Marijin Lijffijt’s LinkedIn: https://www.linkedin.com/in/cns-treatment-innovation/
Sama Therapeutics: https://sama.ac/
-
Interview with Dr. Paul Le Floch. We talk about his journey thus far, his start-up (Axoft), clinical translation, the current neurotech landscape, the future of neurotech, and more. Recorded: January 15, 2024. Co-hosts: Robert Murcko and Yuqing Wang. [Subscribe to free neurotech newsletter: https://neurotechnologynews.beehiiv.com/subscribe]. [Axoft Website: https://axoft.us/]
